QM1: ACEI in heart failure | 61.4 | 16.7 | 57 |
|
QM2: Influenza immunisation in patients aged >65 years | 70.4 | 5.52 | 71 |
|
QM3: Stop smoking advice and nicotine replacement | 59.6 | 27.3 | 52 |
|
QM4: Screening and treatment of hypertension | 73.3 | 14.2 | 52 |
|
QM5: Aspirin in ischaemic heart disease | 67.7 | 13.4 | 52 |
|
QM6: Warfarin in atrial fibrillation | 47.7 | 20.9 | 51 |
|
QM7: Statins in ischaemic heart disease | 59.6 | 14.7 | 53 |
|
Composite quality score I: heath gain weights | 63.9 | 10.41 | 49 |
|
Composite quality score II: equal weights | 62.8 | 10.3 | 49 |
|
| Cost £ | | |
E1: ACEI spend per ASTRO97-PU | 1.16 | 0.25 | 57 |
|
E2: Influenza spend per patient aged >65 years | 4.61 | 1.28 | 71 |
|
E3: Smoking spend per patient aged 15–75 years | 1.41 | 0.51 | 52 |
|
E4: BP spend per patient aged >45 years | 37.2 | 7.39 | 51 |
|
E5: Aspirin spend per ASTRO97-PU | 0.05 | 0.02 | 53 |
|
E6: Warfarin spend per ASTRO97-PU | 0.06 | 0.02 | 50 |
|
E7: Statin spend per ASTRO97-PU | 2.26 | 0.56 | 53 |
|
Sum total spend per patient | 30.89 | 6.32 | 71 |
|
Sum total spend per ASTRO97-PU | 6.22 | 1.08 | 71 |
|
Sum of mean spend per appropriate prescribing unit | 45.92 | 1.47 | 49 |